by editor | May 30, 2014 | Participants
High quality data answers important questions Principal Investigator to the Australian arm of the ASPREE trial, Professor John McNeil says health authorities require a high level of evidence about the balance of benefits and risks of aspirin in healthy people...
by editor | May 16, 2014 | Clinicians, Participants
Together we’ve reached a number of very important recruitment milestones! 1) ASPREE participants in the USA and Australia = 16,500 2) ASPREE participants in Australia = 14,500 3) ASPREE participants in Victoria = 10,500 4) ASPREE participants in Tasmania =...
Recent Comments